Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Reexamination Certificate
2008-05-06
2008-05-06
Graser, Jennifer E. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
C424S130100, C424S141100, C424S150100, C530S387100, C530S388100
Reexamination Certificate
active
11348437
ABSTRACT:
The isolation of genes and proteins fromStaphylococcus aureusis provided, and the nucleic acids coding for specific regions of theS. aureusCIfA protein are described. The nucleic acids encode proteins that can be useful as vaccines or in pharmaceutical compositions for application to prevent infection, promotion of wound healing, blocking adherence to indwelling medical devices, or diagnosis of infection.
REFERENCES:
McDevitt et al (Molec. Microbiol., Jan. 1994, 11(2): 237-248).
Foster Timothy James
McDevitt Damien Leo
Graser Jennifer E.
Schulman B. Aaron
Stites & Harbison PLLC
The Provost Fellows and Scholars of the College of the Holy and
LandOfFree
S. aureus fibrinogen binding protein gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S. aureus fibrinogen binding protein gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S. aureus fibrinogen binding protein gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3904896